DALERBA; PIERO D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DALERBA; PIERO D..The latest application filed is for "treatment of cancer with dual targeting of cd47 and egfr".

Company Profile

2.6.9

DALERBA; PIERO D. - NEW YORK NY
Dalerba; Piero D. - Palo Alto CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Treating Adenoid Cystic Carcinoma App 20220031644 - DALERBA; PIERO D. ; et al.	2022-02-03
Treatment Of Cancer With Dual Targeting Of Cd47 And Egfr App 20220033506 - Weissman; Irving L. ; et al.	2022-02-03
Treatment of cancer with dual targeting of CD47 and EGFR Grant 11,130,813 - Weissman , et al. September 28, 2	2021-09-28
Methods For Treating, Preventing And Detecting The Prognosis Of Colorectal Cancer App 20210292400 - HAN; Yiping W. ; et al.	2021-09-23
Treatment Of Cancer With Dual Targeting Of Cd47 And Egfr App 20190322751 - Weissman; Irving L. ; et al.	2019-10-24
Treatment of cancer with dual targeting of CD47 and EGFR Grant 10,344,094 - Weissman , et al. July 9, 2	2019-07-09
Methods and systems for analysis of single cells Grant 9,850,483 - Clarke , et al. December 26, 2	2017-12-26
Treatment Of Cancer With Dual Targeting Of Cd47 And Egfr App 20170166645 - Weissman; Irving L. ; et al.	2017-06-15
Single Cell Gene Expression For Diagnosis, Prognosis And Identification Of Drug Targets App 20160312302 - Clarke; Michael F. ; et al.	2016-10-27
Single cell gene expression for diagnosis, prognosis and identification of drug targets Grant 9,329,170 - Clarke , et al. May 3, 2	2016-05-03
Methods And Systems For Analysis Of Single Cells App 20130225435 - Clarke; Michael F. ; et al.	2013-08-29
Single cell gene expression for diagnosis, prognosis and identification of drug targets App 20100255471 - Clarke; Michael F. ; et al.	2010-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.